Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Active, not recruiting Not applicable

The Role of Empathy in the Links Between Binge Eating Disorder and Interpersonal Difficulties

NCT07201662 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2025-11-05
Last updated
2026-01-12

Condition(s) studied

Obesity &Amp;Amp; Overweight

Investigational drug(s) / intervention(s)

Condensed and Revised Multifaceted Empathy TestHospital Anxiety and Depression ScaleInterpersonal Reactivity IndexVicarious Distress QuestionnaireBinge Eating Scale

Condensed and Revised Multifaceted Empathy Test: Experimental emotional decoding task that measures the cognitive and affective dimensions of empathy based on performance (Edele et al., 2013; Grynberg et al., 2017).Participants view 40 photos of faces expressing either a positive or negative emotion and must identify the emotion (decoding) and then rate on a 1-9 scale the extent to which they share it (emotional sharing). The task lasts approximately 10 minutes on average.

Hospital Anxiety and Depression Scale: A self-administered scale with 14 items, divided into two subscales of seven items, used to detect the presence of depression and anxiety. Non-cases or asymptomatic individuals (score ≤ 7); probable or borderline cases (score 8-10); clearly or clinically symptomatic cases (score ≥ 11). The administration time is approximately 5 minutes.

Interpersonal Reactivity Index: The Interpersonal Reactivity Index (Davis, 1980; Guttman \& Laporte, 2002) is a 28-item self-report questionnaire measuring four dimensions of empathy: fantasy, perspective taking, empathic concern, and personal distress. Each item is rated on a 1-to-5 scale and provides a subscore for each dimension, with no overall total score. Administration takes approximately 5 minutes.

Vicarious Distress Questionnaire: The Vicarious Distress Questionnaire (Grynberg et al., 2012) is an 18-item self-report scale assessing distress experienced in response to others' suffering and its impact on prosocial behaviors. It includes three dimensions-distress, support, and avoidance-each yielding a specific subscore. Administration takes approximately 5 minutes.

Binge Eating Scale: The Binge Eating Scale (Gormally et al., 1982; Brunault et al., 2016) is a 16-item self-report questionnaire assessing the behavioral, emotional, and cognitive manifestations of binge eating disorder (BED) according to DSM-V criteria. The total score (0-46) reflects symptom severity and can be interpreted dimensionally or categorically (≥ 18 indicating significant symptomatology). Administration takes approximately 5 minutes.

Study summary

Obesity, recognized as a chronic disease by the WHO since 1998, affects 22.1% of adults in the Hauts-de-France region. Beyond the physiological aspects, it is associated with psychological difficulties, particularly eating disorders such as binge eating disorder (BED), as well as interpersonal difficulties related to empathy. Empathy, which consists of cognitive (decoding emotion) and affective (sharing emotion) dimensions, appears to be reduced in obese adults compared to adults of normal weight. However, existing research remains limited and heterogeneous. It is therefore essential to explore the links between obesity, cognitive and affective empathy in greater detail, taking into account the role of BED, in order to better understand their impact on interpersonal relationships.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age ≥ 18 years * BMI ≥ 30 kg/m2 * French-speaking * Enrolled in nutritional rehabilitation * Written consent signed by the patient * Affiliation with a social security system Exclusion Criteria: * Insufficient proficiency in the French language * Minor patients, or patients under legal protection measures or deprived of liberty * Lack of health insurance coverage * Refusal to participate in the study * Presence of neurological disorders * Presence of cognitive disorders * Presence of psychiatric disorders * Presence of eating disorders such as anorexia or bulimia

Primary outcome measure(s)

  • MET-Core — Enrollment
    Compare cognitive empathy skills obtained on the MET-Core between participants who are obese

Trial sites (1)

FacilityCityRegionStatus
Clinique les Peupliers Villeneuve-d'Ascq France
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07201662 on ClinicalTrials.gov ↗ ← All trials in France